Disease model | Methods | Subsets | Signature | Conversion | Function | Publication |
---|---|---|---|---|---|---|
5 × FAD | scRNA-seq | DAM | ↓: P2ry12/P2ry13, Cx3cr1, Tmem119 ↑: ApoE, Ctsd, Lpl, Tyrobp and Trem2 | Two-Step Activation Mechanism: First step, Trem2-independent; Second step, Trem2-dependent | Participating in the clearance of amyloid β | Keren-Shaul et al. [21] |
4-month-APP/PS1 | Single-cell mass cytometry with fluorescence cytometry | Confirm the DAM | ↑: CD11c and CD14 | Mrdjen et al. [184] | ||
SOD1G93A APP/PS1, EAE mice | RNA-seq | MGnD | ↓: Homeostatic genes ↑: Inflammatory molecules, such as ApoE | Trem2-APOE pathway | Krasemann et al. [103] | |
CK-p25 | scRNA-seq | Proliferating microglia (early stage) | Mathys et al. [104] | |||
MHC-II (later stage) | ↑: Class II components genes | |||||
IFN-I (later stage) | ↑: Type I interferon response gene | |||||
Trem2-/-, 18–20 months old, 6-month-old 5 × FAD | scRNA-seq | WAMs | ↓: Homeostatic genes and checkpoint genes ↑: DAM-associated genes | In aged mice: age and Trem2 dependent; In AD model: age and Trem2, ApoE dependent | Clearing degenerated myelin | Safaiyan et al. [22] |
PS2APP, 5 × FAD, APPswe/PS1De9 and two tau models: P301S/L | RNA-seq | Confirm the DAM and IFN-I | Friedman et al. [183] | |||
Proliferating microglia | Expressing proliferation module ↑:slightly: mitosis genes |